Vital Therapies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch VTL and buy or sell other stocks, options, and ETFs commission-free!

About VTL

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. 

CEO
Daniel Vitt, PhD
CEODaniel Vitt, PhD
Employees
Employees
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2003
Founded2003
Employees
Employees

VTL Key Statistics

Market cap
117.81M
Market cap117.81M
Price-Earnings ratio
-0.62
Price-Earnings ratio-0.62
Dividend yield
Dividend yield
Average volume
758.18K
Average volume758.18K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$3.11
52 Week high$3.11
52 Week low
$0.9451
52 Week low$0.9451
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.